Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-009491
Filing Date
2015-11-05
Accepted
2015-11-05 06:53:05
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nvet-10q_20150930.htm 10-Q 1967948
2 EX-31.1 nvet-ex311_7.htm EX-31.1 9783
3 EX-31.2 nvet-ex312_8.htm EX-31.2 9475
4 EX-32.1 nvet-ex321_6.htm EX-32.1 7343
5 EX-32.2 nvet-ex322_9.htm EX-32.2 7344
  Complete submission text file 0001564590-15-009491.txt   7741256

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvet-20150930.xml EX-101.INS 1876267
7 XBRL TAXONOMY EXTENSION SCHEMA nvet-20150930.xsd EX-101.SCH 54130
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvet-20150930_cal.xml EX-101.CAL 39254
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvet-20150930_def.xml EX-101.DEF 166802
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvet-20150930_lab.xml EX-101.LAB 391148
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvet-20150930_pre.xml EX-101.PRE 308076
Mailing Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000
Business Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36828 | Film No.: 151198712
SIC: 2834 Pharmaceutical Preparations